90 related articles for article (PubMed ID: 23825222)
1. miR-17 targets tissue inhibitor of metalloproteinase 1 and 2 to modulate cardiac matrix remodeling.
Li SH; Guo J; Wu J; Sun Z; Han M; Shan SW; Deng Z; Yang BB; Weisel RD; Li RK
FASEB J; 2013 Oct; 27(10):4254-65. PubMed ID: 23825222
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction.
Glass C; Singla DK
Cell Transplant; 2012; 21(9):1931-44. PubMed ID: 22449760
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease.
Martinez EC; Lilyanna S; Wang P; Vardy LA; Jiang X; Armugam A; Jeyaseelan K; Richards AM
J Mol Cell Cardiol; 2017 Nov; 112():27-39. PubMed ID: 28865712
[TBL] [Abstract][Full Text] [Related]
4. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
[TBL] [Abstract][Full Text] [Related]
5. The role of Parkin protein in cardiac function and ventricular remodeling in myocardial infarction rats.
Zhang SX; Zhuang LL; Liu J; Jing YY; Sun J; Gong L; Liu XY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):5004-5013. PubMed ID: 30070337
[TBL] [Abstract][Full Text] [Related]
6. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
[TBL] [Abstract][Full Text] [Related]
7. [In vivo interleukin-10 gene transfer down-regulates myocardial matrix metalloproteinase and myocardial collagen expressions in rats with acute myocardial infarction].
Hu CY; Ding WH; Han XN; Chu SY; Hao YJ; Bu DF
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Mar; 36(3):243-8. PubMed ID: 19099983
[TBL] [Abstract][Full Text] [Related]
8. Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction.
Tsujita K; Kaikita K; Hayasaki T; Honda T; Kobayashi H; Sakashita N; Suzuki H; Kodama T; Ogawa H; Takeya M
Circulation; 2007 Apr; 115(14):1904-11. PubMed ID: 17389263
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
[TBL] [Abstract][Full Text] [Related]
10. Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice.
Wang J; Gao Y; Ma M; Li M; Zou D; Yang J; Zhu Z; Zhao X
Cell Biochem Biophys; 2013 Nov; 67(2):537-46. PubMed ID: 23443810
[TBL] [Abstract][Full Text] [Related]
11. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
Tian H; Cimini M; Fedak PW; Altamentova S; Fazel S; Huang ML; Weisel RD; Li RK
J Mol Cell Cardiol; 2007 Dec; 43(6):733-43. PubMed ID: 17945252
[TBL] [Abstract][Full Text] [Related]
12. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
[TBL] [Abstract][Full Text] [Related]
13. Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction.
Fang L; Gao XM; Samuel CS; Su Y; Lim YL; Dart AM; Du XJ
Clin Sci (Lond); 2008 Aug; 115(3):99-106. PubMed ID: 18248324
[TBL] [Abstract][Full Text] [Related]
14. Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure.
Cardin S; Guasch E; Luo X; Naud P; Le Quang K; Shi Y; Tardif JC; Comtois P; Nattel S
Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):1027-35. PubMed ID: 22923342
[TBL] [Abstract][Full Text] [Related]
15. A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis.
Liang H; Zhang C; Ban T; Liu Y; Mei L; Piao X; Zhao D; Lu Y; Chu W; Yang B
Int J Biochem Cell Biol; 2012 Dec; 44(12):2152-60. PubMed ID: 22960625
[TBL] [Abstract][Full Text] [Related]
16. Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.
Angoulvant D; Fazel S; Weisel RD; Lai TY; Fedak PW; Chen L; Rafati S; Seneviratne CK; Degousee N; Li RK
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):471-80. PubMed ID: 19185172
[TBL] [Abstract][Full Text] [Related]
17. HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3.
Limana F; Esposito G; D'Arcangelo D; Di Carlo A; Romani S; Melillo G; Mangoni A; Bertolami C; Pompilio G; Germani A; Capogrossi MC
PLoS One; 2011; 6(6):e19845. PubMed ID: 21731608
[TBL] [Abstract][Full Text] [Related]
18. Regional cardiac dysfunction is associated with specific alterations in inflammatory cytokines and matrix metalloproteinases after acute myocardial infarction in sheep.
Gallagher G; Menzie S; Huang Y; Jackson C; Hunyor SN
Basic Res Cardiol; 2007 Jan; 102(1):63-72. PubMed ID: 16817025
[TBL] [Abstract][Full Text] [Related]
19. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
Xu X; Wan W; Ji L; Lao S; Powers AS; Zhao W; Erikson JM; Zhang JQ
Cardiovasc Res; 2008 Jun; 78(3):523-32. PubMed ID: 18252761
[TBL] [Abstract][Full Text] [Related]
20. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
